Exploratory Screening for Biomarkers of Early Severe Acute Pancreatitis Using Widely Targeted Metabolomics
Year: 2026
Type: article
Study design: Observational Study
Abstract: To identify serum biomarkers for early risk stratification of severe acute pancreatitis (SAP) using widely targeted metabolomics in an exploratory discovery cohort. Serum samples from 11 healthy controls, 44 patients with mild acute pancreatitis (MAP), and 20 SAP patients were analyzed by UPLC-MS/MS Multivariate statistical analyses (principal component analysis [PCA] and Orthogonal partial least squares discriminant analysis [OPLS-DA]) were applied to compare metabolic profiles. Candidate biomarkers were screened by VIP > 1, p < 0.05, and AUC > 0.9, followed by pathway enrichment and diagnostic performance evaluation. The three groups showed gradient metabolic separation. A total of 353 differentially expressed metabolites were detected between SAP and MAP, with glycerophospholipid metabolism as the most significantly enriched pathway. Among the top 20 metabolites ranked by VIP, five had AUC > 0.9. After excluding three substances prone to exogenous interference, Asp-Leu-Ala-Glu and 3-hydroxytetradecanoic acid were retained as potential endogenous candidate biomarkers for SAP. These metabolites were significantly elevated in SAP compared to MAP, with no significant difference observed between MAP and healthy controls, achieving AUCs of 0.914 (95% CI: 0.835-0.973) and 0.935 (95% CI: 0.849-0.991), respectively. Progression to SAP involves characteristic metabolic reprogramming dominated by glycerophospholipid metabolism. The two identified metabolites are promising candidate biomarkers for early risk stratification of SAP.
Source: Biomedical Chromatography
DOI: 10.1002/bmc.70662
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Award: G6216344709
OpenAlex ID: W7235437859
